The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Open accessAbstract
CONTEXT: Aspirin reduces risk of colorectal neoplasia in randomized trials and inhibits tumor growth and metastases in animal models. However, the influence of aspirin on survival after diagnosis of colorectal cancer is unknown. OBJECTIVE: To examine the association between aspirin use after colorectal cancer diagnosis on colorectal cancer-specific and overall survival. DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort study of 1279 men and women diagnosed with stage I, II, or III colorectal cancer. Participants were enrolled in 2 nationwide health professional cohorts in 1980 and 1986 prior to diagnosis and followed up through June 1, 2008. MAIN OUTCOME MEASURE: Colorectal cancer-specific and overall mortality. RESULTS: After a median follow-up of 11.8 years, there were 193 total deaths (35%) and 81 colorectal cancer-specific deaths (15%) among 549 participants who regularly used aspirin after colorectal cancer diagnosis, compared with 287 total deaths (39%) and 141 colorectal cancer-specific deaths (19%) among 730 participants who did not use aspirin. Compared with nonusers, participants who regularly used aspirin after diagnosis experienced a multivariate hazard ratio (HR) for colorectal cancer-specific mortality of 0.71 (95% confidence interval [CI], 0.53-0.95) and for overall mortality of 0.79 (95% CI, 0.65-0.97). Among 719 participants who did not use aspirin before diagnosis, aspirin use initiated after diagnosis was associated with a multivariate HR for colorectal cancer-specific mortality of 0.53 (95% CI, 0.33-0.86). Among 459 participants with colorectal cancers that were accessible for immunohistochemical assessment, the effect of aspirin differed significantly according to cyclooxygenase 2 (COX-2) expression (P for interaction = .04). Regular aspirin use after diagnosis was associated with a lower risk of colorectal cancer-specific mortality among participants in whom primary tumors overexpressed COX-2 (multivariate HR, 0.39; 95% CI, 0.20-0.76), whereas aspirin use was not associated with lower risk among those with primary tumors with weak or absent expression (multivariate HR, 1.22; 95% CI, 0.36-4.18). CONCLUSION: Regular aspirin use after the diagnosis of colorectal cancer is associated with lower risk of colorectal cancer-specific and overall mortality, especially among individuals with tumors that overexpress COX-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,575
Reproducibility and validity of a semiquantitative food frequency questionnaire
WILLETT, W. C., SAMPSON, L., STAMPFER, M. J., ROSNER, B., BAIN, C., WITSCHI, J., HENNEKENS, C. H., & SPEIZER, F. E. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114086 · Cited by 4,274
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., & Dubois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,514
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Rimm, E. B., Giovannucci, E. L., Stampfer, M. J., Colditz, G. A., Litin, L. B., & Willett, W. C. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116211 · Cited by 2,104
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021735 · Cited by 1,416
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398
American Joint Committee On Cancer (2010) · Springer eBooks · doi:10.1007/978-0-387-88443-1 · Cited by 1,386
Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021633 · Cited by 1,136
Aspirin and the Risk of Colorectal Cancer in Women
Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331001 · Cited by 1,090
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
Bertagnolli, M. M., Eagle, C. J., Zauber, A. G., Redston, M., Solomon, S. D., Kim, K., Tang, J., Rosenstein, R. B., Wittes, J., Corle, D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061355 · Cited by 1,048
Celecoxib for the Prevention of Colorectal Adenomatous Polyps
Arber, N., Eagle, C. J., Spicak, J., Rácz, I., Dite, P., Hajer, J., Zavoral, M., Lechuga, M. J., Gerletti, P., Tang, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061652 · Cited by 975
Systemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Physical activity and survival after colorectal cancer diagnosis
Meyerhardt, J. A., Giovannucci, E. L., Holmes, M. D., Chan, A. T., Chan, J. A., Colditz, G. A., & Fuchs, C. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.0855 · Cited by 857
TEST OF THE NATIONAL DEATH INDEX
STAMPFER, M. J., WILLETT, W. C., SPEIZER, F. E., DYSERT, D. C., LIPNICK, R., ROSNER, B., & HENNEKENS, C. H. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113804 · Cited by 790
Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals
Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., & Willett, W. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00001 · Cited by 785
Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2
Chan, A. T., Ogino, S., & Fuchs, C. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067208 · Cited by 781
Self-citationInhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D., & DuBois, R. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119400 · Cited by 712
Host cyclooxygenase-2 modulates carcinoma growth
Williams, C. S., Tsujii, M., Reese, J., Dey, S. K., & DuBois, R. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9621 · Cited by 673
Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells
Sheng, H., Shao, J., Washington, M. K., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009689200 · Cited by 653
Test of the National Death Index and Equifax Nationwide Death Search
Rich-Edwards, J. W., Corsano, K. A., & Stampfer, M. J. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117191 · Cited by 530
Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer
Chan, A. T. (2005) · JAMA · doi:10.1001/jama.294.8.914 · Cited by 478
Self-citationThe Relationship Between Cyclooxygenase-2 Expression and Colorectal Cancer
Sheehan, K. M. (1999) · JAMA · doi:10.1001/jama.282.13.1254 · Cited by 461
COX-2: A Molecular Target for Colorectal Cancer Prevention
Brown, J. R., & DuBois, R. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.051 · Cited by 444
A Randomized Trial of Rofecoxib for the Chemoprevention of Colorectal Adenomas
Baron, J. A., Sandler, R. S., Bresalier, R. S., Quan, H., Riddell, R., Lanas, A., Bolognese, J. A., Oxenius, B., Horgan, K., Loftus, S., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.079 · Cited by 433
Aspirin and Folic Acid for the Prevention of Recurrent Colorectal Adenomas
Logan, R. F. A., Grainge, M. J., Shepherd, V. C., Armitage, N. C., & Muir, K. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.014 · Cited by 398
Benamouzig, R., Deyra, J., Martin, A., Girard, B., Jullian, E., Piednoir, B., Couturier, D., Coste, T., Little, J., & Chaussade, S. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00887-4 · Cited by 395
Dubé, C., Rostom, A., Lewin, G., Tsertsvadze, A., Barrowman, N., Code, C., Sampson, M., & Moher, D. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00009 · Cited by 334
Williams, C. S., Watson, A. J. M., Sheng, H., Helou, R. A., Shao, J., & DuBois, R. N. (2000) · PubMed · Cited by 318
Lundholm, K., Gélin, J., Hyltander, A. G., Lönnroth, C., Sandström, R., Svaninger, G., Körner, U., Gulich, M. P., Kärrefors, I., & Norli, B. (1994) · PubMed · Cited by 309
Masunaga, R., Kohno, H., Dhar, D. K., Ohno, S., Shibakita, M., Kinugasa, S., Yoshimura, H., Tachibana, M., Kubota, H., & Nagasue, N. (2000) · PubMed · doi:10.11501/3179825 · Cited by 290
Schwenger, P., Bellosta, P., Vietor, I., Basilico, C., Skolnik, E. Y., & Vilček, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2869 · Cited by 274
A Prospective Study of Aspirin Use and Primary Prevention of Cardiovascular Disease in Women
Manson, J. E. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470040085027 · Cited by 272
Cianchi, F., Cortesini, C., Bechi, P., Fantappiè, O., Messerini, L., Vannacci, A., Sardi, I., Baroni, G., Boddi, V., Mazzanti, R., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.29691 · Cited by 255
Ogino, S., Brahmandam, M., Cantor, M., Namgyal, C., Kawasaki, T., Kirkner, G., Meyerhardt, J. A., Loda, M., & Fuchs, C. S. (2006) · Modern Pathology · doi:10.1038/modpathol.3800482 · Cited by 252
Soumaoro, L. T., Uetake, H., Higuchi, T., Takagi, Y., Enomoto, M., & Sugihara, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0653 · Cited by 250
Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in Men
Chan, A. T., Giovannucci, E. L., Meyerhardt, J. A., Schernhammer, E. S., Wu, K., & Fuchs, C. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.09.035 · Cited by 242
Self-citationGum, P. A., Thamilarasan, M., Watanabe, J., Blackstone, E. H., & Lauer, M. S. (2001) · JAMA · doi:10.1001/jama.286.10.1187 · Cited by 238
Tomozawa, S., Tsuno, N. H., Sunami, E., Hatano, K., Kitayama, J., Osada, T., Saito, S., Tsuruo, T., Shibata, Y., & Nagawa, H. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1270 · Cited by 224
Yao, M., Kargman, S., Lam, E. C., Kelly, C. R., Zheng, Y., Luk, P., Kwong, E. C., Evans, J. F., & Wolfe, M. M. (2003) · PubMed · Cited by 213
Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer
Ogino, S., Kirkner, G. J., Nosho, K., Irahara, N., Kure, S., Shima, K., Hazra, A., Chan, A. T., Dehari, R., Giovannucci, E. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1841 · Cited by 209
Self-citationChen, W., Wei, S., Liu, J. M., Hsiao, M., Kou‐Lin, J., & Yang, W. K. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200102)9999:9999<894::aid-ijc1146>3.0.co;2-# · Cited by 196
Martínez, M. E., O'Brien, T. G., Fultz, K. E., Babbar, N., Yerushalmi, H., Qu, N., Guo, Y., Boorman, D., Einspahr, J., Alberts, D. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332465100 · Cited by 196
Trifan, O. C., Durham, W. F., Salazar, V. S., Horton, J., Levine, B. D., Zweifel, B. S., Davis, T. W., & Masferrer, J. L. (2002) · PubMed · Cited by 195
A Prospective Study of Aspirin Use and the Risk for Colorectal Adenoma
Chan, A. T., Giovannucci, E. L., Schernhammer, E. S., Colditz, G. A., Hunter, D. J., Willett, W. C., & Fuchs, C. S. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00006 · Cited by 166
Self-citationA novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells.
Goel, A., Chang, D. K., Ricciardiello, L., Gasché, C., & Boland, C. R. (2003) · PubMed · Cited by 148
Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer
Zhang, H. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)03981-3 · Cited by 142
Tomozawa, S., Nagawa, H., Tsuno, N. H., Hatano, K., Osada, T., Kitayama, J., Sunami, E., Nita, M. E., Ishihara, S., Yano, H., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6694262 · Cited by 112
Yao, M., Lam, E., Kelly, C. R., Zhou, W., & Wolfe, M. M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601489 · Cited by 107
Yao, M., Zhou, W., Sangha, S., Albert, A., Chang, A. J., Liu, T. C., & Wolfe, M. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1696 · Cited by 104
Aspirin and Colon Cancer — Targeting Prevention?
Markowitz, S. D. (2007) · New England Journal of Medicine · doi:10.1056/nejme078044 · Cited by 77
Lin, J., Hsiao, P.-W., Chiu, T. H., & Chao, J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.028 · Cited by 72
Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint
Jankowski, J. A., & Hunt, R. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0710 · Cited by 72
Cyclooxygenase-2 Expression in Human Colorectal Cancer Is Unrelated to Overall Patient Survival
Fux, R., Schwab, M. G., Thon, K., Gleiter, C. H., & Fritz, P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2586 · Cited by 69
Yamauchi, T., Watanabe, M., Hasegawa, H., Nishibori, H., Ishii, Y., Tatematsu, H., Yamamoto, K., Kubota, T., & Kitajima, M. (2003) · PubMed · Cited by 51
Expression of Cyclooxygenase-2 Protein in Colorectal Carcinomas
Joo, Y., Kim, H., Min, S.-W., Lee, W., Park, C., Park, C., Choi, S.-K., Rew, J., & Kim, S.-J. (2002) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:31:1-3:147 · Cited by 50
Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Point
Arber, N. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0167 · Cited by 48
A Cyclooxygenase-2 Inhibitor (SC-58125) Blocks Growth of Established Human Colon Cancer Xenografts
Williams, C. S., Sheng, H., Brockman, J. A., Armandla, R., Shao, J., Washington, M. K., ELKAHLOUN, A. G., & DuBois, R. N. (2001) · Neoplasia · doi:10.1038/sj.neo.7900177 · Cited by 38
Buchanan, F. G., Chang, W., Sheng, H., Shao, J., Morrow, J. D., & DuBois, R. N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.025 · Cited by 32
Uchida, K., Schneider‐Burrus, S., Yochim, J. M., Kuramochi, H., Hayashi, K., Takasaki, K., Yang, D., Danenberg, K. D., & Danenberg, P. V. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1650 · Cited by 30
Aspirin is Clinically Effective in Chemoprevention of Colorectal Neoplasia: Point
Leshno, M., Moshkowitz, M., & Arber, N. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0259 · Cited by 20
Cited by
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Rothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
Rothwell, P. M., Wilson, M., Price, J. F., Belch, J. F., Meade, T. W., & Mehta, Z. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60209-8 · Cited by 984
Metadata
- Authors
- Chan, A. T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2009-08-12
- Volume
- 302
- Issue
- 6
- Pages
- 649
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2068978328
- Cited by
- 557
- References
- 64
- FWCI
- 31.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.